Glycopyrrolate
Links shared publicly online about this topic
CUVPOSA (Glycopyrrolate) drug information from MPR
empr.com — “CUVPOSA (Glycopyrrolate) drug information for Drooling from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on July 22, 2011 at 4:29 am By:
MPR News: CUVPOSA: Monograph added. http://bit.ly/oEZhow
Age, Glycopyrrolate Spotted as Pediatric Propofol Risks
acep.org — “Age, Glycopyrrolate Spotted as Pediatric Propofol Risks” View full resource at acep.org
Most Recently Shared on August 13, 2011 at 7:20 am By:
Matt Weidman Pediatrician, Physician, and Doctor
Age, Glycopyrrolate Spotted as Pediatric Propofol Risks http://t.co/KofY2ki #pediatrics #sedation
Glycopyrrolate shortage hits human, veterinary medicine - VIN
news.vin.com — “Glycopyrrolate shortage hits human, veterinary medicine - VIN” View full resource at news.vin.com
Most Recently Shared on February 26, 2011 at 4:44 pm By:
Yet another drug shortage. As industry consolidates, this is becoming a bigger problem for vets http://ow.ly/44fK4
Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Drooling In Pediatric Patients
medicalnewstoday.com — “Sciele Pharma, Inc., a Shionogi company, announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to tr” View full resource at medicalnewstoday.com
Most Recently Shared on September 29, 2009 at 4:53 pm By:
MNT Neurology News Neurology and Health News
Sciele Pharma Submits New Drug Application To FDA For Glycopyrrolate Oral Solution, A Treatment For Chronic Dro.. http://tinyurl.com/y8llzwr
Medical News: FDA Approves Drug to Control Kids' Chronic Drooling - in Pediatrics, General Pediatrics from MedPage Today
medpagetoday.com — “A new formulation of glycopyrrolate (Cuvposa) has received FDA approval to treat chronic severe drooling in children ages 3 to 16, the agency said.” View full resource at medpagetoday.com
Most Recently Shared on July 29, 2010 at 3:07 pm By:
FDA Approves Drug to Control Kids' Chronic Drooling (MedPage Today) -- A new formulation of glycopyrrolate (Cuvposa) ha.. http://dld.bz/pnvt
FDA Approves Drug For Chronic Drooling In Children
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.” View full resource at medicalnewstoday.com
Most Recently Shared on July 29, 2010 at 3:07 pm By:
MNT Neurology News Neurology and Health News
FDA Approves Drug For Chronic Drooling In Children http://mnt.to/3GJs #neurology
FDA Approves Cuvposa for Chronic Drooling in Children
drugs.com — “Cuvposa (glycopyrrolate) is used to treat chronic severe drooling. Includes Cuvposa side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2010 at 10:14 pm By:
FDA Approves Cuvposa for Chronic Drooling in Children - http://bit.ly/d837HK
Medical News: FDA Approves Drug to Control Kids' Chronic Drooling - in Pediatrics, General Pediatrics from MedPage Today
medpagetoday.com — “A new formulation of glycopyrrolate (Cuvposa) has received FDA approval to treat chronic severe drooling in children ages 3 to 16, the agency said.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 6:00 am By:
Jay Gordon, MD, FAAP Doctor, Pediatrician, Health Communicator, and Physician
Medical progress marches on: http://bit.ly/dpVbUd
Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patients With Neurologic Conditions
medicalnewstoday.com — “Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patie” View full resource at medicalnewstoday.com
Most Recently Shared on July 30, 2010 at 11:39 am By:
Shionogi Inc. Announces FDA Approval Of CUVPOSA For The Treatment Of Chronic Severe Drooling In Pediatric Patients... http://mnt.to/f/3GLX
Psychiatry Medical News about Schizophrenia
mdlinx.com — “Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: A randomized, double-blind, crossover study” View full resource at mdlinx.com
Most Recently Shared on March 22, 2010 at 6:38 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialo... http://bit.ly/cLlvmY #PSY
CUVPOSA - New Product Releases - MPR
empr.com — “To reduce chronic severe drooling in patients 3--16yrs of age with neurologic conditions associated with problem drooling (eg, cerebral palsy).” View full resource at empr.com
Most Recently Shared on April 22, 2011 at 2:31 pm By:
MPR News: CUVPOSA: Glycopyrrolate 1mg/5mL; soln; cherry-flavored. http://bit.ly/fQABRJ
COPD Treatment a Clinical Trial Success | www.dailyrx.com
dailyrx.com — “COPD Treatment a Clinical Trial Success | www.dailyrx.com” View full resource at dailyrx.com
Most Recently Shared on December 11, 2011 at 2:08 am By:
Michael Blaiss, MD Physician, Doctor, and Allergist
Glycopyrrolate had positive results in phase 2b clinical trials in COPD http://t.co/yrC4IhB2
FDA approves Cuvposa Oral Solution for chronic severe drooling in children
news-medical.net — “The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.” View full resource at news-medical.net
Most Recently Shared on July 29, 2010 at 6:01 am By:
FDA approves Cuvposa Oral Solution for chronic severe drooling in children: The U.S. Food and Drug Administration ... http://bit.ly/cogyuk
Cuvposa approved for chronic severe drooling associated with neurologic conditions - MPR
empr.com — “The FDA has approved Cuvposa (glycopyrrolate liquid, from Shionogi), an orphan drug, for the treatment of chronic severe drooling associated with neurologic conditions (eg, cerebral palsy) in patients 3"16 years of age.” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: Cuvposa approved for chronic severe drooling associated with neurologic conditions: The FDA has approved... http://bit.ly/ar1eRe
US FDA approves Cuvposa oral solution for chronic drooling in kids - International
pharmabiz.com — “The US Food and Drug Administration approved Cuvposa (glycopyrrolate) oral solution to treat chronic severe drooling caused by neurologic disorders in children ages three years to 16 years.” View full resource at pharmabiz.com
Most Recently Shared on July 30, 2010 at 11:39 am By:
US FDA approves Cuvposa oral solution for chronic drooling in kids: The US Food and Drug Administration approved C... http://bit.ly/bXhGLf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Matt Weidman
Husband, father of five girls, pediatrician, blogger, nerd
-
Keith Niesenbaum
Owner of Crawford Dog and Cat Hospital, www.TheVetsChoice.com, www.CrawfordDogandCatHospital.com www.Facebook.com/crawforddogandcat
Advertisement
